Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Career
    • Practice Management
      • Reimbursement & Coding
      • Legal
      • Operations
    • Awards
    • Certification
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Compensation Reports
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • By the Numbers
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • mTBI Resource Center
    • ACEP.org
    • ACEP Knowledge Quiz
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • Issue Archives
  • Archives
    • Brief19
    • Coding Wizard
    • Images in EM
    • Care Team
    • Quality & Safety
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Table 2: Selected Dosing of Anticoagulants in Patients with DVT. Note that limited data are available for morbidly obese patients, while patients with mass less than 57 kg for men and less than 45 kg for women are at increased risk of bleeding with heparins.1,2

By Joseph Harrington | on August 14, 2016 | 0 Comment
Share:  Print-Friendly Version

Table 2: Selected Dosing of Anticoagulants in Patients with DVT. Note that limited data are available for morbidly obese patients, while patients with mass less than 57 kg for men and less than 45 kg for women are at increased risk of bleeding with heparins.1,2

You Might Also Like
  • The Moral Challenge of Morbidly Obese ED Patients
  • Obese Women May Need Double Dose of LNG-based Emergency Contraception
  • NOAC Bleeding No More Dangerous than Warfarin Bleeding

Table 2: Selected Dosing of Anticoagulants in Patients with DVT. Note that limited data are available for morbidly obese patients, while patients with mass less than 57 kg for men and less than 45 kg for women are at increased risk of bleeding with heparins.1,2

Current Issue

ACEP Now: March 2026

Download PDF

Read More

About the Author

Joseph Harrington

View this author's posts »

No Responses to “Table 2: Selected Dosing of Anticoagulants in Patients with DVT. Note that limited data are available for morbidly obese patients, while patients with mass less than 57 kg for men and less than 45 kg for women are at increased risk of bleeding with heparins.1,2”

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*



Current Issue

ACEP Now: March 2026

Download PDF

Read More

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603